Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist

Stephen Atkin, E. A. Masson, L. D. Blumhardt, M. C. White

Research output: Contribution to journalArticle

4 Citations (Scopus)


The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).

Original languageEnglish
Pages (from-to)371-372
Number of pages2
JournalJournal of Neurology Neurosurgery and Psychiatry
Issue number3
Publication statusPublished - 1994
Externally publishedYes


ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this